References
- Schobben A. F.A.M. Pharmacokinetics and therapeutics in epilepsy, PhD Thesis. Nijmegen. 1979
- Van Dijk A., Klein S., Van Heijst A.N.P., Glerum J. H. Simultaneous determination of primidone, PEMA and phenobar-bitone in plasma. Pharm. Weekblad., submitted for publication 1983
- De Groot G. Hemoperfusion in clinical toxicology, PhD Thesis. Utrecht. 1982
- Bogue J. Y., Carrington H. C. The evaluation of “Mysoline” -a new anticonvulsant drug. Brit. J. Pharmacol. 1953; 8: 230–235
- Handley R., Stewart A. S.R. Mysoline: a new drug in the treatment of epilepsy. Lancet 1952; 1: 742–744
- Schottelius D. D. Primidone: absorption, distribution, and excretion. Antiepileptic Drugs, D.M. Woodbury, J.K. Penry, C.E. Pippenger. Raven Press, New York 1982; 405–413
- Huisman J. W. Disposition of primidone in man: an example of auto-induction of a human enzyme system. Pharm. Weekblad. 1969; 104: 799–802
- Martindale W. The Extra Pharmacopoeia, 27th edition. Pharmaceutical Press, London 1978
- Arnold O. H., Ceranke- S., Höfermayer. Ein Fall von Suicidversuch mit Mysoline. Wien. Med. Wschr. 1953; 103: 692–693
- Dotevall G., Herner B. Treatment of Acute Primidone Poisoning with Bemegride and Amiphenazole. Brit. Med. J. 1957; 2: 451–452
- Morley D., Wynne N. A. Acute primidone poisoning in a child. Brit. Med. J. J. 1957; 90
- Fazekas J., Renger B. Tödliche Vergiftung (Selbstmord) mit Mysoline und Phenobarbiturat. Arch. Toxikol. 1960; 18: 213–223
- Del F., Greco, Arieff A. J. Primidone (Mysoline) and glutethimide (Doriden) intoxication (biotransformation to barbiturate). Arch. Neurol. 1962; 7: 244
- Bogan J., Rentoul E., Smith H. Fatal poisoning by primidone. J. Forens. Sci. Soc 1965; 5: 97
- Plaa G. L., Fugimoto J. M., Hine C. H. Intoxication from primidone due to its biotransformation to phenobarbital. JAMA 1958; 168: 179–180
- Gallagher B. B., Baumel I. P., Mattson R. H., Woodbury S. G. Primidone, diphenylhydantoin and phenobarbital: Aspects of acute and chronic toxicity. Neurology 1973; 23: 145–149
- Brillmann J., Gallagher B. B., Mattson R. H. Acute Primidone intoxication. Arch. Neurol. 1974; 30: 255–258
- Lagenstein I., Sternowsky H. J., Iffland E., Blaschke E. Intoxication with primidone: continuous monitoring of serum primidone and its metabolites during forced diuresis. Neuro-padiatrie 1977; 8: 190–195
- Guelen P. J., Van der Kleijn E., Woudstra U. Statistical analysis of pharmacokinetic parameters in epileptic patients chronically treated with antiepileptic drugs. Clinical pharmacology of antiepileptic drugs, H. Schneider, D. Janz, C. Gardner-Thorpe, H. Meinardi, A.L. Sherwin. Springer Verlag, Berlin 1975; 2–10
- Lee C. S.C., Marbury T. C., Perchalski R. T., Wilder B. J. Pharmacokinetics of primidone elimination by uremic patients. J. Clin. Pharmacol. 1982; 22: 301–308
- Nau H., Kuhnz W., Egger H. J., Rating D., Helge H. Anticonvulsants during pregnancy and lactation: transplacental, maternal and neonatal pharmacokinetics. Clin. Pharmacokin. 1982; 7: 508–543
- Zavadil P., Gallagher B. B. Metabolism and excretion of l4C-primidone in epileptic patients. Epileptology, D. Janz. Thieme Verlag, Stuttgart 1976; 129–139
- Cottrell P. R., Streete J. M., Berry D. J., Sch H., äfer, Pisani F., Perucca E., Richens A. Pharmacokinetics of phenylethylmalonamide (PEMA) in normal subjects and in patients treated with antiepileptic drugs. Epilepsia 1982; 23: 307–313